I was wondering about that...private placement was at 3.6 if I’m not mistaken. I think they will just hold and not worry. Only newbies and people who play with margin or borrowed funds worry more
Please stay away from all the glove counters that hit very high prices in the past couple of months. Their large daily swings clearly indicate that they are fully controlled by syndicates. The syndicates or so called fund managers are doing things in their stride. Retail investors will be killed. As such please stay away 100% from all the BIG GLOVES' BOYS.
The biggest threat to Gloves are not vaccines but overcapacity & over production of gloves on the way mah....!!
Posted by Keyman188 > Dec 30, 2020 5:11 PM | Report Abuse
AstraZeneca-Oxford Covid Vaccine Gains First Clearance With U.K. Nod
(December 30, 2020, 3:06 PM GMT+8 Updated on December 30, 2020, 4:08 PM GMT+8)
~ Vaccinations to start in new year as cases rise across Britain
~ Recipients to get second shot within 12 weeks of first one
AstraZeneca Plc and the University of Oxford’s Covid-19 vaccine won U.K. clearance, marking the first approval worldwide for a shot that’s faced questions but will be key to mass immunizations.
The vaccine will be prioritized for the country’s most vulnerable groups, with shots starting Monday, according to the government. It’s the second coronavirus injection to be cleared for emergency use in the U.K. after Pfizer Inc. and BioNTech SE’s in early December.
The move will help the U.K. ramp up vaccination and provides vindication for the homegrown shot, which has drawn scrutiny over discrepancies in its clinical-trial results. The shot can be deployed swiftly because it’s easier to transport and store than the Pfizer-BioNTech one, requiring only refrigerator temperatures rather than deep freezing. The U.K. has bought 100 million doses.
A first dose of the AstraZeneca-Oxford vaccine will be given to as many people as possible, followed by a second shot four to 12 weeks later. A government advisory group said the priority should be to vaccinate large numbers as quickly as possible rather than completing a two-dose regimen right away.
AstraZeneca shares rose as much as 1.8% early Wednesday in London.
The approval comes as the U.K. seals its divorce from the European Union with a trade deal and tightens lockdowns amid a new surge on coronavirus infections that’s straining hospitals. The U.K. reported a record number of fresh daily Covid cases Tuesday, as a new variant of the pathogen raises concern globally.
The country’s vaccination program has advanced quickly, with more than 600,000 people given shots by Christmas. The U.S. is immunizing an average of only 200,000 people a day, with many states having used just a small percentage of the shipments sent to them this month.
“We will start to get ahead of the pandemic, protect health and economies when the vulnerable are vaccinated everywhere,” said Andrew Pollard, Oxford’s lead investigator for the vaccine.
When patients were given two full shots, the vaccine was 62% effective -- less than the Pfizer-BioNTech shot and another from Moderna Inc. A group that accidentally received half of the first dose showed better protection, with efficacy reaching 90%. But participants were 55 years old or less, and because older people who are most at risk of severe Covid-19 often show more sluggish immune responses, the results leave some doubt as to whether the efficacy will stand up to further testing.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Seeyounoup
1,201 posts
Posted by Seeyounoup > 2020-12-29 16:33 | Report Abuse
200 ma break.